Sio Gene Therapies | 15-12G:终止注册
Sio Gene Therapies | EFFECT:其他
Sio Gene Therapies | POS AM:修改注册声明表
Sio Gene Therapies | S-8 POS:员工福利计划证券登记(修正)
Sio Gene Therapies | 25-NSE:由交易所申报的注销已到期、已赎回、已兑付证券的通知
Sio Gene Therapies | 25:注销已到期、已赎回、已兑付证券的通知
Sio Gene Therapies | 8-K:重大事件
Sio Gene Therapies | DEFA14A:其他
Sio Gene Therapies | 8-K:重大事件
Sio Gene Therapies | DEFM14A:并购重组委托书
Sio Gene Therapies | DEFA14A:其他
Sio Gene Therapies | 8-K:SIO基因疗法公司宣布2022财年第三季度财务业绩
Sio Gene Therapies | 10-Q:2023财年三季报
Sio Gene Therapies | SC 13G/A:超过5%持股股东披露文件(修正)-Suvretta Capital Management, LLC(0%),Averill Master Fund, Ltd.(0%)等
Sio Gene Therapies | SC 13G:超过5%持股股东披露文件-Rubric Capital Management LP(9.46%),David Rosen(9.46%)
Sio Gene Therapies | PREM14A:并购处分代理声明
Sio Gene Therapies | DEFA14A:其他
Sio Gene Therapies | 8-K:重大事件
Sio Gene Therapies | 8-K:SIO基因疗法公司宣布2022财年第二季度财务业绩
Sio Gene Therapies | 10-Q:2023财年二季报
暂无数据